CoChat

Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma

Open access

The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.

Abstract

Pseudoprogression (PsP) is a diagnostic clinical dilemma in cancer. In this study, we retrospectively analyse glioblastoma patients, and using their dynamic susceptibility contrast and dynamic contrast-enhanced perfusion MRI images we build a classifier using radiomic features obtained from both Ktrans and rCBV maps coupled with support vector machines. We achieve an accuracy of 90.82% (area under the curve (AUC) = 89.10%, sensitivity = 91.36%, 67 specificity = 88.24%, p = 0.017) in differentiating between pseudoprogression (PsP) and progressive disease (PD). The diagnostic performances of the models built using radiomic features from Ktrans and rCBV separately were equally high (Ktrans: AUC = 94%, 69 p = 0.012; rCBV: AUC = 89.8%, p = 0.004). Thus, this MR perfusion-based radiomic model demonstrates high accuracy, sensitivity and specificity in discriminating PsP from PD, thus provides a reliable alternative for noninvasive identification of PsP versus PD at the time of clinical/radiologic question. This study also illustrates the successful application of radiomic analysis as an advanced processing step on different MR perfusion maps.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-11007-0

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Image post-processing radiomic workflow. a relative cerebral blood volume (rCBV) and Ktrans maps of perfusion MRI are acquired. b Segmentation of the region of interest using 3D slicer software. c Radiomic feature extraction from the whole tumor volume. d Statistical analysis: radiomic and clinical features are analyzed to determince their diagnostic and predictive values
Fig. 1 Image post-processing radiomic workflow. a relative cerebral blood volume (rCBV) and Ktrans maps of perfusion MRI are acquired. b Segmentation of the region of interest using 3D slicer software. c Radiomic feature extraction from the whole tumor volume. d Statistical analysis: radiomic and clinical features are analyzed to determince their diagnostic and predictive valuesCC BY · PubMed Central
Fig. 2 Model building and evaluation using the selected Ktrans features (60 features). a, b ROC curve depicts the predictive model building using C5.0 (P-value 1.512e−11) and SVM methods (P-value 0.003744) respectively. c, d 10-fold cross-validation ROC curve (P-value 1.512e−11) and Leave-One-Out Cross-Validation (LOOCV) ROC curve (P-value 0.004) depicts the performance of the model
Fig. 2 Model building and evaluation using the selected Ktrans features (60 features). a, b ROC curve depicts the predictive model building using C5.0 (P-value 1.512e−11) and SVM methods (P-value 0.003744) respectively. c, d 10-fold cross-validation ROC curve (P-value 1.512e−11) and Leave-One-Out Cross-Validation (LOOCV) ROC curve (P-value 0.004) depicts the performance of the modelCC BY · PubMed Central
Fig. 3 Model building and evaluation using the selected rCBV features (160 features). a, b ROC curve depicts the predictive model building using C5.0 (P-value 1.512e−11) and SVM methods (P-value 0.012) respectively. c, d 10-fold cross-validation ROC curve (P-value 1.512e−11) and Leave-One-Out Cross-Validation (LOOCV) ROC curve (P-value 0.012) depicts the performance of the model
Fig. 3 Model building and evaluation using the selected rCBV features (160 features). a, b ROC curve depicts the predictive model building using C5.0 (P-value 1.512e−11) and SVM methods (P-value 0.012) respectively. c, d 10-fold cross-validation ROC curve (P-value 1.512e−11) and Leave-One-Out Cross-Validation (LOOCV) ROC curve (P-value 0.012) depicts the performance of the modelCC BY · PubMed Central
Fig. 4 Model building and evaluation using the selected merged Ktrans and rCBV features (60 features). a, b ROC curve depicts the predictive model building using C5.0 (P-value 1.512e−11) and SVM methods (P-value 0.017), respectively. c, d 10-fold cross-validation ROC curve (P-value 1.512e−11) and Leave-One-Out Cross-Validation (LOOCV) ROC curve (P-value 0.02) depicts the performance of the model
Fig. 4 Model building and evaluation using the selected merged Ktrans and rCBV features (60 features). a, b ROC curve depicts the predictive model building using C5.0 (P-value 1.512e−11) and SVM methods (P-value 0.017), respectively. c, d 10-fold cross-validation ROC curve (P-value 1.512e−11) and Leave-One-Out Cross-Validation (LOOCV) ROC curve (P-value 0.02) depicts the performance of the modelCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 2

  1. Zinn, P. O. et al. A coclinical radiogenomic validation study: conserved magnetic resonance radiomic appearance of periostin-expressing glioblastoma in patients and xenograft models. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-17-3420 (2018). · DOI · Paper page
  2. Vojt et al. in Proceedings of the 28th International Conference on International Conference on Machine Learning 665-672 (Omnipress, Bellevue, Washington, USA, 2011).

Cited by

See all 158

Metadata

Authors
Elshafeey, N., Kotrotsou, A., Hassan, A., Elshafei, N., Hassan, I., Ahmed, S., Abrol, S., Agarwal, A., El Salek, K., Bergamaschi, S., Acharya, J., Moron, F. E., Law, M., Fuller, G. N., Huse, J. T., Zinn, P. O., & Colen, R. R.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • University of Southern California (US)
  • University of Pittsburgh (US)
Corresponding author
  • Zinn, Pascal O.
  • Colen, Rivka R.
Venue
Nature Communications
Published
2019-07-18
Volume
10
Issue
1
Pages
3170-3170
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2958189178
Cited by
147
References
58
Citations by year
2026: 8 · 2025: 13 · 2024: 15 · 2023: 23 · 2022: 29 · 2021: 28 · 2020: 30 · 2019: 1
FWCI
14.52
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Monash University Research Portal (Monash University) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Radiological Society of North America (RSCH11506)
  • Cancer Prevention and Research Institute of Texas (RP160150)
  • UT | University of Texas MD Anderson Cancer Center (P30CA016672)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Brain Tumor Detection and Classification
Keywords
glioblastoma, pseudoprogression, dynamic susceptibility contrast MRI, dynamic contrast-enhanced MRI, perfusion MRI, radiomic features, Ktrans, relative cerebral blood volume, support vector classifier, progressive disease, treatment response assessment
MeSH terms
Brain Neoplasms, Female, Glioblastoma, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Disease Progression, Support Vector Machine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. https://app.cochat.ai/papers/10.1038/s41467-019-11007-0
The paper
Elshafeey, N., Kotrotsou, A., Hassan, A., Elshafei, N., Hassan, I., Ahmed, S., Abrol, S., Agarwal, A., El Salek, K., Bergamaschi, S., Acharya, J., Moron, F. E., Law, M., Fuller, G. N., Huse, J. T., Zinn, P. O., & Colen, R. R. (2019). Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nature Communications. https://doi.org/10.1038/s41467-019-11007-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.